This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
Delivered as Hybrid Event from 30 Oct - 1 Nov 2023
Live In-Person Conference Delivered 30 Oct -1 NovAmsterdam

Stephen Lock, PhD
Senior Marketing and Market Development Manager, BioPharma, EMEAI at SCIEX


Dr. Stephen Lock obtained his PhD in Physical Organic Chemistry from the University College of Swansea in 1993 and is a chartered chemist and a member of the Royal Society of Chemistry.  Previously a lecturer of Chemistry at the University of Hull and a senior scientist at CCFRA he has worked for SCIEX™ in various technical roles for over 20 years. He has over 25 years’ experience in Analytical Chemistry and has presented at over 80 international meetings around the world covering applications of CE, CE-MS and LC-MS. Steve is currently the EMEAI Biopharma Senior Marketing and Market Development Manager of SCIEX and was also recently appointed in a volunteer role as an Adjunct Professor at the University of Pannonia to act as a Scientific Advisor for the Horváth Csaba Memorial Laboratory lead by Prof. Andras Guttman. At the Horváth Csaba Memorial Laboratory Steve provides technical advice and supports the groups fundamental research and development of new applications in the area of CE and CE-MS.

Agenda Sessions

  • Highly Sensitive Characterization and Quantification of Oligonucleotide Impurities and Metabolites by LC-MS